Display options
Share it on

Antivir Ther. 2018;23(8):711. doi: 10.3851/IMP3261.

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.

Antiviral therapy

George V Papatheodoridis, Eirini I Rigopoulou, Margarita Papatheodoridi, Kalliopi Zachou, Vassilios Xourafas, Nikolaos Gatselis, Emilia Hadziyannis, John Vlachogiannakos, Spilios Manolakopoulos, George N Dalekos

Affiliations

  1. Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
  2. Department of Medicine and Research Laboratory of Internal Medicine, Thessaly University Medical School, Larissa, Greece.
  3. 2nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

PMID: 30091421 DOI: 10.3851/IMP3261

[No abstract available.]

Publication Types